Erschienen in:
01.10.2012 | Cardiac Computed Tomography (TC Villines and S Achenbach, Section Editors)
Coronary Computed Tomography Angiography: Costs and Current Reimbursement Status
verfasst von:
Edward Hulten, Rosco Gore, Marcio Sommer Bittencourt, Michael K. Cheezum, Todd C. Villines
Erschienen in:
Current Cardiovascular Imaging Reports
|
Ausgabe 5/2012
Einloggen, um Zugang zu erhalten
Abstract
Coronary computed tomography angiography (CCTA) has evolved as the most sensitive diagnostic non-invasive test for diagnosing coronary artery disease (CAD). Outcomes data is accumulating and demonstrating that CCTA has excellent prognostic value. Given CCTA’s consistently proven accuracy and improved safety related to radiation sparing techniques, public health officials have called for comparative cost-effectiveness research of CCTA vs other diagnostic testing strategies for assessing possible angina in symptomatic patients. In this article, we review the available cost studies of CCTA in comparison with other diagnostic strategies. Currently available data are limited but include 5 completed randomized trials, 11 observational studies, 7 studies using theoretical mathematical modeling, and 4 reports of the cost impact of incidental findings on CCTA. Additional randomized trials including cost considerations are ongoing, but evidence from available randomized, observational, and theoretical modeling data mostly support CCTA as a potentially cost-saving, non-invasive test for the evaluation of CAD in symptomatic patients.